PT1363600E - Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas - Google Patents

Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas Download PDF

Info

Publication number
PT1363600E
PT1363600E PT02721011T PT02721011T PT1363600E PT 1363600 E PT1363600 E PT 1363600E PT 02721011 T PT02721011 T PT 02721011T PT 02721011 T PT02721011 T PT 02721011T PT 1363600 E PT1363600 E PT 1363600E
Authority
PT
Portugal
Prior art keywords
treatment
prevention
disorders
liquid formulations
mucosal diseases
Prior art date
Application number
PT02721011T
Other languages
English (en)
Inventor
Jeremy E Jacob
David P Nowotnik
Christiane M Baud
Original Assignee
Access Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Access Pharma Inc filed Critical Access Pharma Inc
Publication of PT1363600E publication Critical patent/PT1363600E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT02721011T 2001-02-15 2002-02-15 Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas PT1363600E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26904901P 2001-02-15 2001-02-15

Publications (1)

Publication Number Publication Date
PT1363600E true PT1363600E (pt) 2008-12-22

Family

ID=23025584

Family Applications (2)

Application Number Title Priority Date Filing Date
PT81611857T PT1997478E (pt) 2001-02-15 2002-02-15 Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas
PT02721011T PT1363600E (pt) 2001-02-15 2002-02-15 Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT81611857T PT1997478E (pt) 2001-02-15 2002-02-15 Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas

Country Status (12)

Country Link
US (1) US7547433B2 (pt)
EP (2) EP1997478B1 (pt)
AT (1) ATE409458T1 (pt)
CA (1) CA2441352C (pt)
CY (1) CY1108678T1 (pt)
DE (1) DE60229109D1 (pt)
DK (2) DK1363600T3 (pt)
ES (2) ES2314049T3 (pt)
HK (1) HK1126134A1 (pt)
NZ (1) NZ549469A (pt)
PT (2) PT1997478E (pt)
WO (1) WO2002064113A1 (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002041837A2 (en) * 2000-11-22 2002-05-30 Rxkinetix, Inc. Treatment of mucositis
GB0126064D0 (en) * 2001-10-30 2001-12-19 Reckitt Benckiser Healthcare Improvements in or relating to organic compositions
US7132111B2 (en) * 2003-01-03 2006-11-07 Epien Medical, Inc. Odorless formulation for treating mucosal discontinuities
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
EP1660101A4 (en) * 2003-08-21 2010-02-24 Access Pharma Inc LIQUID FORMULATIONS FOR THE PREVENTION AND TREATMENT OF SLAUGHTER DISEASES AND DISORDERS
DE20318634U1 (de) * 2003-11-13 2004-02-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
AU2005268926B2 (en) 2004-08-02 2011-10-13 Glaxosmithkline Consumer Healthcare (Uk) Ip Limited Novel composition for xerostomia
AR053332A1 (es) * 2005-02-16 2007-05-02 Wyeth Corp Uso de agonistas selectivos para el receptor-beta de estrogeno (erp) para la mucositis inducida por radiacion o por quimioterapia y para la cistitis inducida por radiacion
AU2016202290B2 (en) * 2005-06-17 2017-10-05 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
HUE054887T2 (hu) 2005-06-17 2021-10-28 Wisconsin Alumni Res Found Topikális érösszehúzó készítmények és eljárások sejtek védelmére rák kemoterápia és radioterápia alatt
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2007064755A2 (en) * 2005-11-30 2007-06-07 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant
EP2037941B8 (en) * 2006-05-30 2015-07-01 OraHealth Corporation Cobalamin compositions for treating or preventing mucositis
WO2008137831A1 (en) * 2007-05-07 2008-11-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Water-soluble nanoparticles containing water-insoluble compounds
EP3354276B1 (en) 2007-11-13 2020-01-01 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
EP3695835A1 (en) 2009-02-03 2020-08-19 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
AU2010259284A1 (en) * 2009-06-10 2011-12-15 Exthera Ab Use of a composition for the treatment of mucositis
IT1397132B1 (it) * 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
US20110237563A1 (en) * 2010-03-23 2011-09-29 Dominique Costantini Fast dissolving drug delivery systems
US20120053130A1 (en) * 2010-08-30 2012-03-01 Bristol-Myers Squibb Company Composition for enhancing absorption of a drug and method
EP2658538A2 (en) * 2010-12-30 2013-11-06 M.D. Ziv Harish Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
US10426761B2 (en) * 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
CN103619341A (zh) * 2011-04-19 2014-03-05 Arms制药有限公司 抑制有害微生物的方法及其阻隔形成组合物
ES2375784B1 (es) * 2011-12-22 2013-01-24 Laboratorios Kin S.A. Gel de ácido tranexámico
RU2625550C2 (ru) 2013-02-13 2017-07-14 Дзе Проктер Энд Гэмбл Компани Ароматизированное анисом лекарственное средство
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
AU2014237970B2 (en) * 2013-03-15 2017-01-05 Cook Medical Technologies Llc Adhesive medical products and methods for treating gastrointestinal lesions
US9433644B2 (en) 2013-07-25 2016-09-06 Rutgilli Pharmaceuticals, Llc Formulations and methods for treating oral inflammation, injury, or pain
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
WO2015116860A1 (en) * 2014-01-29 2015-08-06 Vita Ice Therapeutics Llc Edible oil compositions to treat oral complications and methods of using same
WO2015126841A1 (en) 2014-02-18 2015-08-27 Plasmatech Biopharmaceuticals, Inc. Nutritional and therapeutic mucoadhesive formulations
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
EP3213760A4 (en) * 2014-10-27 2018-06-20 FBM Indústria Farmacêutica Ltda. Soluble, stable, anti-inflammatory, proliferative, protective and mucoadhesive pharmaceutical compositions; use thereof for treating mucositis conditions and method for producing same; base pharmaceutical composition for preparing the pharmaceutical compositions and method for producing same
CN110177542A (zh) 2016-11-28 2019-08-27 强生消费者公司 包含黏膜粘着剂的液体组合物
US11413240B2 (en) * 2016-12-29 2022-08-16 Board Of Regents, The University Of Texas System Methylene blue solution for the treatment of oral lesions
FR3063226B1 (fr) * 2017-02-28 2020-05-08 Unither Pharmaceuticals Formulation pharmaceutique pour l'administration par voie bucco-gingivale de paracetamol
WO2019067680A1 (en) 2017-09-27 2019-04-04 Cook Medical Technologies Llc CROSSLINKING SUBMUCOSAL INJECTION SYSTEM
AU2019312592A1 (en) 2018-07-31 2021-02-18 Microbion Corporation Bismuth-thiol compositions and methods for treating wounds
CA3107760A1 (en) 2018-07-31 2020-02-06 Microbion Corporation Bismuth-thiol compositions and methods of use
MX2022010104A (es) 2020-02-18 2022-09-05 Sunstar Americas Inc Composicion para el cuidado bucal.

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
AU565354B2 (en) 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
US4738842A (en) 1986-01-17 1988-04-19 Riker Laboratories Topical antiinflammatory compositions
US4851393A (en) * 1986-07-28 1989-07-25 Massachusetts Institute Of Technology Method for utilizing an exocellular polysaccharide isolated from zoogloea ramigera
US5081158A (en) 1988-05-02 1992-01-14 Zila Pharmaceuticals, Inc. Compositions and in situ methods for forming films on body tissue
EP0431719B1 (en) 1989-10-31 1994-11-09 Columbia Laboratories, Inc. Vaginal tissue moisturizing composition
US6017521A (en) 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
JP2510052B2 (ja) 1989-10-31 1996-06-26 コロンビア ラボラトリーズ インコーポレイテッド 組織与湿組成物及び方法
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5543150A (en) 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
US5403578A (en) 1994-02-08 1995-04-04 Gordon; Norman Stable tooth and gum dentifrice with microencapsulation and method for making same
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW438601B (en) 1994-05-18 2001-06-07 Janssen Pharmaceutica Nv New mucoadhesive emulsion compositions and a process for the preparation thereof
AU3726395A (en) * 1994-09-27 1996-04-19 Virotex Corporation Improved topical carriers for mucosal applications
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US20030098438A1 (en) * 1998-06-29 2003-05-29 Haslin Leonard Arthur Environmentally friendly compositions having antiicing, deicing or graffiti prevention properties
IT1277663B1 (it) * 1995-09-28 1997-11-11 Crinos Industria Farmaco Sospensioni acquose stabili di mesalazina per uso topico
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
GB9610862D0 (en) 1996-05-23 1996-07-31 Evans Brian K Pharmaceutical products
SE9602644D0 (sv) * 1996-07-04 1996-07-04 Astra Ab New use
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US5900230A (en) 1997-08-18 1999-05-04 Squigle, Inc. Dental products to treat and prevent periodontal disease
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US20020009478A1 (en) 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
AU4673099A (en) * 1999-02-26 2000-09-14 Chiron Corporation Use of bioadhesives and adjuvants for the mucosal delivery of antigens
US6375963B1 (en) 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
WO2001068079A2 (en) 2000-03-14 2001-09-20 Alcon, Inc Viscoelastics for use in middle ear surgery
IT1318649B1 (it) 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
US20020103219A1 (en) 2000-10-05 2002-08-01 Jeremy Jacob Stable viscous liquid formulations of amlexanox for the prevention and treatment of mucosal diseases and disorders
US20030060447A1 (en) * 2002-04-24 2003-03-27 Mutlu Karakelle Non-aspirating transitional viscoelastics for use in surgery
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders

Also Published As

Publication number Publication date
DK1997478T3 (da) 2013-12-09
NZ549469A (en) 2009-02-28
ES2314049T3 (es) 2009-03-16
ATE409458T1 (de) 2008-10-15
CA2441352C (en) 2010-05-25
WO2002064113A1 (en) 2002-08-22
HK1126134A1 (en) 2009-08-28
CA2441352A1 (en) 2002-08-22
US20020168334A1 (en) 2002-11-14
EP1363600A1 (en) 2003-11-26
CY1108678T1 (el) 2014-04-09
DE60229109D1 (de) 2008-11-13
US7547433B2 (en) 2009-06-16
EP1997478A3 (en) 2008-12-10
EP1997478A2 (en) 2008-12-03
PT1997478E (pt) 2013-12-10
EP1363600B1 (en) 2008-10-01
EP1997478B1 (en) 2013-09-04
ES2437846T3 (es) 2014-01-14
DK1363600T3 (da) 2009-01-26

Similar Documents

Publication Publication Date Title
HK1126134A1 (en) Liquid formulations for the prevention and treatment of mucosal diseases and disorders
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
WO2003018619A3 (en) Antimicrobial and anti-inflammatory peptides
BR9914718A (pt) Formulações farmacêuticas de libertação controlada compreendendo um inibidor cgmp pde-5
AUPR213700A0 (en) Antiviral agents
EE05392B1 (et) Aerosoolina manustatav optimeeritud tobramtsiinipreparaat
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
NO20034612L (no) 3,4-di-substituerte syklobuten-1,2-dioner, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for tilvirkning av medikamenter for behandling av kjemokinformidlede sykdommer
HK1073996A1 (en) Use of adapalene for the treatment of dermatological disorders
HK1088895A1 (pt)
BR9903273A (pt) Formulações intranasais para o tratamento de desordens sexuais
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
DE60205455T2 (de) Naphthyridinderivate
WO2002028860A3 (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
BR0010546A (pt) Terapia antiinflamatória para infecção mediada inflamatória
DK1684719T3 (da) Alfa-1-antitrypsin-sammensætninger og behandlingsfremgangsmåder, der anvender sådanne sammensætninger
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
WO2005023792A3 (en) Macrocyclic compounds useful as pharmaceuticals
SE0001916D0 (sv) Novel formulation
WO2002000208A3 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
EP1122261A3 (en) 13 and 14-membered antibacterial macrolides
SE0102639D0 (sv) Novel compounds
WO2002070537A3 (en) Fusidic acid derivatives
WO2003063788A3 (en) PTPase INHIBITORS AND METHODS OF USING THE SAME